Is the Pathological Chemotherapy Response Score (CRS) a Surrogate for Survival? - An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery.

Laura Feeney

Is the Pathological Chemotherapy Response Score (CRS) a Surrogate for Survival? - An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery.

Laura Feeney

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to conference › Poster › peer-review

Original language	English
Publication status	Published - 14 Sept 2018
Event	International Gynecological Cancer Society - Kyoto, Japan Duration: 14 Sept 2018 → 16 Sept 2018

Conference

Conference	International Gynecological Cancer Society
Abbreviated title	IGCS
Country/Territory	Japan
City	Kyoto
Period	14/09/2018 → 16/09/2018

Cite this

@conference{e17d89a2eefa4745884bca3250d168ff,

title = "Is the Pathological Chemotherapy Response Score (CRS) a Surrogate for Survival? - An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery.",

author = "Laura Feeney",

year = "2018",

month = sep,

day = "14",

language = "English",

note = "International Gynecological Cancer Society, IGCS ; Conference date: 14-09-2018 Through 16-09-2018",

}

Is the Pathological Chemotherapy Response Score (CRS) a Surrogate for Survival? - An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery. / Feeney, Laura.
2018. Poster session presented at International Gynecological Cancer Society, Kyoto, Japan.

Research output: Contribution to conference › Poster › peer-review

TY - CONF

T1 - Is the Pathological Chemotherapy Response Score (CRS) a Surrogate for Survival? - An International Multicentre Collaborative Analysis of High-Grade Serous Tubo-Ovarian Carcinoma Treated with Neoadjuvant Chemotherapy and Interval Debulking Surgery.

AU - Feeney, Laura

PY - 2018/9/14

Y1 - 2018/9/14

M3 - Poster

T2 - International Gynecological Cancer Society

Y2 - 14 September 2018 through 16 September 2018

ER -